| 000 | 01071 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250512064128.0 | ||
| 264 | 0 | _c19871120 | |
| 008 | 198711s 0 0 eng d | ||
| 022 | _a0003-4819 | ||
| 024 | 7 |
_a10.7326/0003-4819-107-5-759 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGordon, D J | |
| 245 | 0 | 0 |
_a3-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: a new class of cholesterol-lowering agents. _h[electronic resource] |
| 260 |
_bAnnals of internal medicine _cNov 1987 |
||
| 300 |
_a759-61 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAnticholesteremic Agents _xadverse effects |
| 650 | 0 | 4 |
_aCholesterol, LDL _xblood |
| 650 | 0 | 4 |
_aCoronary Disease _xprevention & control |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHydroxymethylglutaryl-CoA Reductase Inhibitors |
| 650 | 0 | 4 |
_aLovastatin _xadverse effects |
| 700 | 1 | _aRifkind, B M | |
| 773 | 0 |
_tAnnals of internal medicine _gvol. 107 _gno. 5 _gp. 759-61 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.7326/0003-4819-107-5-759 _zAvailable from publisher's website |
| 999 |
_c3667989 _d3667989 |
||